| Evaluating the cost utility of racecadotril for the treatment of acute watery diarrhea in children: the RAWD model TA Rautenberg, U Zerwes, D Foerster, R Aultman ClinicoEconomics and Outcomes Research, 109-116, 2012 | 42 | 2012 |
| The REVAMP trial to evaluate HIV resistance testing in sub-Saharan Africa: a case study in clinical trial design in resource limited settings to optimize effectiveness and cost … MJ Siedner, MB Bwana, MYS Moosa, M Paul, S Pillay, S McCluskey, ... HIV clinical trials 18 (4), 149-155, 2017 | 20 | 2017 |
| Resistance testing for management of HIV virologic failure in sub-Saharan Africa: an unblinded randomized controlled trial MJ Siedner, MYS Moosa, S McCluskey, RF Gilbert, S Pillay, I Aturinda, ... Annals of internal medicine 174 (12), 1683-1692, 2021 | 12 | 2021 |
| Health economic decision tree models of diagnostics for dummies: a pictorial primer T Rautenberg, A Gerritsen, M Downes Diagnostics 10 (3), 158, 2020 | 12 | 2020 |
| Cost utility, budget impact, and scenario analysis of racecadotril in addition to oral rehydration for acute diarrhea in children in Malaysia TA Rautenberg, U Zerwes, WS Lee ClinicoEconomics and Outcomes Research, 169-178, 2018 | 9 | 2018 |
| The cost utility and budget impact of adjuvant racecadotril for acute diarrhea in children in Thailand TA Rautenberg, U Zerwes ClinicoEconomics and Outcomes Research, 411-422, 2017 | 8 | 2017 |
| Methods to construct a step-by-step beginner’s guide to decision analytic cost-effectiveness modeling T Rautenberg, C Hulme, R Edlin ClinicoEconomics and Outcomes Research, 573-581, 2016 | 8 | 2016 |
| Economic outcomes of sequences which include monoclonal antibodies against vascular endothelial growth factor and/or epidermal growth factor receptor for the treatment of … T Rautenberg, U Siebert, D Arnold, J Bennouna, S Kubicka, S Walzer, ... Journal of medical economics 17 (2), 99-110, 2014 | 8 | 2014 |
| Evaluating the cost utility of racecadotril in addition to oral rehydration solution versus oral rehydration solution alone for children with acute watery diarrhea in four low … TA Rautenberg, M Downes, PHT Kiet, N Ashoush, AR Dennis, K Kim Journal of Medical Economics 25 (1), 274-281, 2022 | 4 | 2022 |
| Meta-analysis of health state utility values measured by EuroQol 5-dimensions (EQ5D) questionnaire in Chinese women with breast cancer T Rautenberg, B Hodgkinson, U Zerwes, M Downes BMC cancer 22, 1-13, 2022 | 4 | 2022 |
| Who’s slipping through the cracks? A comprehensive individual, clinical and health system characterization of people with virological failure on first‐line HIV treatment in … Z Reynolds, SM McCluskey, MYS Moosa, RF Gilbert, S Pillay, I Aturinda, ... HIV medicine 23 (5), 474-484, 2022 | 4 | 2022 |
| Clinical and economic burden of benign and malignant skin lesions in renal transplant recipients Z Thet, AK Lam, T Pham, SK Ng, JC Steel, S Sawhney, CT Arellano, ... Internal Medicine Journal 53 (11), 2042-2049, 2023 | 2 | 2023 |
| Comparative analyses of published cost effectiveness models highlight critical considerations which are useful to inform development of new models TA Rautenberg, G George, MB Bwana, MS Moosa, S Pillay, ... Journal of medical economics 23 (3), 221-227, 2020 | 2 | 2020 |
| Evaluating the cost utility of estradiol plus dydrogesterone for the treatment of menopausal women in China R Tamlyn Anne, M Downes, T Simoncini, Q Yu, M Ren, Y Wang, ... Journal of Medical Economics 27 (1), 16-26, 2024 | 1 | 2024 |
| A cross-sectional study of symptoms and health-related quality of life in menopausal-aged women in China TA Rautenberg, SKA Ng, M Downes BMC Women's Health 23 (1), 563, 2023 | 1 | 2023 |
| Determinants of health-related quality of life in people with Human Immunodeficiency Virus, failing first-line treatment in Africa TA Rautenberg, SK Ng, G George, MYS Moosa, SM McCluskey, ... Health and Quality of Life Outcomes 21 (1), 94, 2023 | | 2023 |
| Seemingly Unrelated Regression Analysis of the Cost and Health-Related Quality of Life Outcomes of the REVAMP Randomized Clinical Trial TA Rautenberg, SK Ng, G George, MYS Moosa, SM McCluskey, ... Value in Health Regional Issues 35, 42-47, 2023 | | 2023 |
| Racecadotril good choice for childhood diarrhoea in Thailand TA Rautenberg PharmacoEconomics & Outcomes News 783, 29-29, 2017 | | 2017 |
| Cost comparison of RNA Disruption Assay (RDA (TM)) versus sonography for response-guided neoadjuvant treatment of breast cancer in germany T Rautenberg, H Rosery ONCOLOGY RESEARCH AND TREATMENT 37, 263-263, 2014 | | 2014 |
| Letter to the editor: author response T Rautenberg Journal of medical economics 17 (6), 443-443, 2014 | | 2014 |
Mark J. SiednerAssociate Professor of Medicine, Harvard Medical School在 partners.org 的电子邮件经过验证
